Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (8)

2024

  1. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

    Science Advances, Vol. 10, Núm. 28

2014

  1. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

2011

  1. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

    Hepatology, Vol. 53, Núm. 1, pp. 23-31

2009

  1. Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells

    Journal of Virology, Vol. 83, Núm. 7, pp. 3298-3311

2008

  1. Cells as vehicles for therapeutic genes to treat liver diseases

    Gene Therapy, Vol. 15, Núm. 10, pp. 765-771

2006

  1. Nuevos tratamientos para la hepatitis C

    Medicina Clinica, Vol. 127, Núm. 3, pp. 104-112

2004

  1. MAGE antigens: Therapeutic targets in hepatocellular carcinoma?

    Journal of Hepatology

2002

  1. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

    Clinical Cancer Research, Vol. 8, Núm. 10, pp. 3219-3225